FVWA
Foster Victor Wealth Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Buy |
363,694
+11,383
| +3% | +$444K | 0.96% | 45 |
|
|
2025
Q1 | $12.2M | Buy |
352,311
+51
| +0% | +$1.77K | 0.98% | 48 |
|
|
2024
Q4 | $11.8M | Buy |
352,260
+79,343
| +29% | +$2.65M | 0.9% | 52 |
|
|
2024
Q3 | $11M | Buy |
272,917
+13,045
| +5% | +$525K | 0.88% | 51 |
|
|
2024
Q2 | $10.1M | Buy |
259,872
+43,422
| +20% | +$1.69M | 0.84% | 51 |
|
|
2024
Q1 | $8.83M | Buy |
216,450
+66,632
| +44% | +$2.72M | 0.81% | 60 |
|
|
2023
Q4 | $5.94M | Buy |
149,818
+5,818
| +4% | +$231K | 0.61% | 61 |
|
|
2023
Q3 | $5.28M | Buy |
144,000
+4,034
| +3% | +$148K | 0.61% | 62 |
|
|
2023
Q2 | $4.86M | Buy |
139,966
+7,588
| +6% | +$264K | 0.54% | 64 |
|
|
2023
Q1 | $4.84M | Buy |
132,378
+6,372
| +5% | +$233K | 0.59% | 60 |
|
|
2022
Q4 | $4.4M | Sell |
126,006
-535
| -0.4% | -$18.7K | 0.56% | 63 |
|
|
2022
Q3 | $3.8M | Buy |
126,541
+9,130
| +8% | +$274K | 0.55% | 63 |
|
|
2022
Q2 | $5.06M | Buy |
117,411
+2,385
| +2% | +$103K | 0.75% | 56 |
|
|
2022
Q1 | $5.26M | Buy |
115,026
+15,370
| +15% | +$703K | 0.72% | 56 |
|
|
2021
Q4 | $4.51M | Buy |
99,656
+18,421
| +23% | +$833K | 0.61% | 61 |
|
|
2021
Q3 | $3.1M | Buy |
81,235
+12,381
| +18% | +$473K | 0.5% | 62 |
|
|
2021
Q2 | $2.74M | Buy |
68,854
+18,784
| +38% | +$748K | 0.46% | 70 |
|
|
2021
Q1 | $1.81M | Buy |
50,070
+23,830
| +91% | +$859K | 0.34% | 80 |
|
|
2020
Q4 | $966K | Buy |
26,240
+12,128
| +86% | +$446K | 0.22% | 84 |
|
|
2020
Q3 | $531K | Buy |
14,112
+7,817
| +124% | +$294K | 0.14% | 92 |
|
|
2020
Q2 | $257K | Buy |
+6,295
| New | +$257K | 0.09% | 103 |
|